cystic fibrosis Mycobacterium Evolution Study Suggests Early Cystic Fibrosis Infection Treatment Mycobacterium abscessus adaptations in the environment and in patients' lungs point to early infection treatment as a measure to help prevent new pathogen emergence. Putting Expanded Carrier Screening Into Practice Requires Considerations to Avoid Pitfalls Premium At an AMP virtual meeting workshop, a Mayo Clinic lab director offered advice on what diseases to include, how to handle VUSs, and other considerations for ECS. Yourgene Inks US Distribution Deal for Chemotoxicity Assay, Other Tests The deal includes UK-based Yourgene's test for detecting cancer patients who may have an adverse reaction to 5-fluorouracil, as well as reproductive health tests. Improved Cytosine Base Editing Tech Eliminates Problem of Undesired Bystander Mutations The percentage of perfectly modified alleles using the new base editor is more than 6,000-fold for disease correction compared with the current BE4max editor. BillionToOne Closes $15M Series A Follow-on Round The firm plans to use the cash to support commercial expansion of its NIPT to all US states and fund R&D for future diagnostic tests, including liquid biopsies. Nov 19, 2019 Paragon Genomics Discusses New Gene Fusion Detection Method, Cystic Fibrosis Panel Premium Oct 31, 2019 Rare Cystic Fibrosis Mutations Dominate in Caribbean Patients Aug 15, 2019 Germline Genome Editing Governance Weighed by International Commission Premium May 8, 2019 BillionToOne to Launch Noninvasive Prenatal Screening Test; Plans Liquid Biopsy Products Premium Apr 17, 2019 Drug Resistance in Cystic Fibrosis Lung Infections Associated With Pseudomonas Bacteriophages Mar 28, 2019 Prenatal Testing Firm BillionToOne Closes $15M Series A Financing Jan 3, 2019 Arbor Biotechnologies, Vertex Pharmaceuticals Partner for Gene-Editing Protein Discovery Aug 1, 2018 New Lung Cell Type Linked to Cystic Fibrosis Emerges From Mouse, Human Cell Atlas Studies May 24, 2018 Functional Assays Improve Classification of Potential Cystic Fibrosis Risk Variants Oct 27, 2017 Australian Study Highlights Carrier Screening Impacts in Reproductive Context Sep 21, 2017 Elucigene Diagnostics to Take US-Specific CF Panel to FDA Next Year as International Sales Spike Premium Aug 18, 2017 Fluidigm Licenses NGS Library Prep Assay for Cystic Fibrosis Gene From Baylor Genetics Aug 2, 2017 Illinois to Use Agena MassArray System for Cystic Fibrosis Screening Nov 10, 2016 Cystic Fibrosis Lung Infections Frequently Involve Bacteria Transmitted Between Humans Nov 2, 2016 Good Start Genetics Selling Carrier Screening Tests Through Amazon Sep 9, 2016 Newborn Carrier Screening May Cause Confusion For Parents, Study Finds Aug 30, 2016 Sophia Genetics' Software to Support Devyser's Diagnostic Kits Aug 18, 2016 Thermo Fisher Launching RUO Women's Health Panel as Clinical PCR Strategy Coalesces Premium May 24, 2016 Genomic Analysis Reveals Burkholderia Mutations, Evolution in Cystic Fibrosis Patient May 16, 2016 Editas Inks $5M Collaboration With Cystic Fibrosis Foundation Therapeutics Load More Breaking News Bruker Posts 34 Percent Jump in Q2 Revenues GenomeWeb Index Gains Slightly in July as Fluidigm, PerkinElmer, Bio-Rad Post Strong Increases Feinstein Institutes for Medical Research Wins $2.9M NIH Grant to Study Polygenic Embryo Screening Top Five Articles on GenomeWeb Last Week: CDC, Bio-Rad, 10x Genomics, PerkinElmer, and More InterVenn Biosciences Closes $201M Series C Round Abcam to Acquire Life Science Research Tool Firm BioVision for $340M The Scan And Back The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database. Lacks Family Hires Attorney A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports. For the Unknown The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona. PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.